Home › Lilly profit beats analyst estimates as Cymbalta sales climb
 

Keywords :   


Lilly profit beats analyst estimates as Cymbalta sales climb

2013-01-29 16:17:05| Agriculture - Topix.net

Eli Lilly and Co.'s fourth quarter earnings slipped 4 percent as generic competition continued to eat away at sales of its former best-seller, the antipsychotic Zyprexa, but the drugmaker cut expenses again and growth from other products helped it beat analyst expectations.

Tags: sales profit estimates analyst

Category:Agriculture and Forestry

Latest from this category

All news
01.11Technology adoption: What's on the ag tech horizon for 2025
01.11Technology adoption: What's on the ag tech horizon for 2025
31.10The winter ahead: Developing La Nina to impact much of the nation
31.10American Hereford appoints new leaders, directors
31.10Robust swine influenza surveillance in place long before H5N1 detection
31.10Trends in pig farming, feeding to be highlighted at EuroTier 2024
31.10Full-fat soybeans: Valuable source of energy, digestible P for pigs
31.10USDA doles out $235 million in disaster aid
Agriculture and Forestry »
01.11Atlantic Tropical Weather Outlook
01.11Eastern North Pacific Tropical Weather Outlook
01.11Boeing makes 38% pay rise offer in bid to end strike
01.11The house paints that promise much more than colour
01.11Eastern North Pacific Tropical Weather Outlook
01.11Atlantic Tropical Weather Outlook
01.11Technology adoption: What's on the ag tech horizon for 2025
01.11Technology adoption: What's on the ag tech horizon for 2025
More »